Search research articles
Contact Us
Filters
Showing results (91-100 of 106) with videos related to
Page
of 11
Sort By:
The Journal of Pathology
|
July 11, 2006
Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse
R Natrajan, R D Williams, S N Hing, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 9, 2015
Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer
F-C Bidard, C K Y Ng, P Cottu, et al.
Oncogene
|
January 22, 2013
Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies
K-K Shiu, D Wetterskog, A Mackay, et al.
The Journal of Pathology
|
September 24, 2008
The genomic profile of HER2-amplified breast cancers: the influence of ER status
C Marchiò, R Natrajan, K K Shiu, et al.
The Journal of Pathology
|
May 14, 2008
Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas
P T Simpson, J S Reis-Filho, M B K Lambros, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 25, 2022
Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing
P Terraf, F Pareja, D N Brown, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 11, 2014
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle
L De Mattos-Arruda, B Weigelt, J Cortes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2022
ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group
J Pascual, G Attard, F-C Bidard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 11, 2022
APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas
P Selenica, A Marra, N J Choudhury, et al.
The Journal of Pathology
|
June 2, 2006
EGFR amplification and lack of activating mutations in metaplastic breast carcinomas
J S Reis-Filho, C Pinheiro, M B K Lambros, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 106) with videos related to
Sort By:
Page
of 11
The Journal of Pathology
|
July 11, 2006
Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse
R Natrajan, R D Williams, S N Hing, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 9, 2015
Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer
F-C Bidard, C K Y Ng, P Cottu, et al.
Oncogene
|
January 22, 2013
Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies
K-K Shiu, D Wetterskog, A Mackay, et al.
The Journal of Pathology
|
September 24, 2008
The genomic profile of HER2-amplified breast cancers: the influence of ER status
C Marchiò, R Natrajan, K K Shiu, et al.
The Journal of Pathology
|
May 14, 2008
Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas
P T Simpson, J S Reis-Filho, M B K Lambros, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 25, 2022
Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing
P Terraf, F Pareja, D N Brown, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 11, 2014
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle
L De Mattos-Arruda, B Weigelt, J Cortes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2022
ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group
J Pascual, G Attard, F-C Bidard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 11, 2022
APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas
P Selenica, A Marra, N J Choudhury, et al.
The Journal of Pathology
|
June 2, 2006
EGFR amplification and lack of activating mutations in metaplastic breast carcinomas
J S Reis-Filho, C Pinheiro, M B K Lambros, et al.
Page
of 11